Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies binding to CD30 and CD3

Antibodies binding to CD30 and CD3

US Patent 11814437 · Granted Nov 14, 2023

Estimated economic value: $8,609,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of 2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Binding agents binding to EpCAM and CD1372025
Binding agents binding to EpCAM and CD1372025
Antibodies binding to fibroblast activation protein alpha and death receptor 42025
Antibody variant combinations and uses thereof2025
Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use t2025
Multispecific antibodies against CD40 and CD1372024
Antibodies2024